Use of Dapagliflozin to Reduce Burden of Atrial Fibrillation in Patients Undergoing Catheter Ablation of Symptomatic Atrial Fibrillation
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to AstraZeneca
Related studies linked through entity extraction aliases.
OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosilicate in Heart Failure
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study to Assess the Effect of Sodium Zirconium Cyclosilicate on the Pharmacokinetics of Tacrolimus and Cyclosporin in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Disease Management Platform for Heart Failure (DMP-HF)
- Status
- COMPLETED
- Phase
- NA
Optimising Secondary Prevention and Quality of Life in Early Cardiac Rehabilitation
- Status
- UNKNOWN
- Phase
- N/A
Study of Durvalumab in Combination With Platinum and Etoposide for the First Line Treatment of Patients With Extensive-stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Evaluate Safety, Tolerability, Pharmacokinetics and Immunogenicity of MEDI7352 in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
A Clinical Trial in Healthy Volunteers and Patients With Mild Asthma to Investigate a New Medicine (AZD4604) for the Treatment of Asthma
- Status
- COMPLETED
- Phase
- PHASE1
Study to Assess the Bioequivalence of Acalabrutinib Tablet and Acalabrutinib Capsule
- Status
- COMPLETED
- Phase
- PHASE1
Durvalumab and Chemotherapy Induction Followed by Durvalumab and Radiotherapy in Large Volume Stage III NSCLC
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Evaluate Chemotherapy Plus Osimertinib Against Chemotherapy Plus Placebo in Patients With Non-small Cell Lung Cancer (NSCLC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Safety and Immunogenicity Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime Boost Regimen for the Prevention of Coronavirus Disease 2019 (COVID-19)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Anifrolumab Early Access Program
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Safety & Efficacy of Consolidative Hypofractionated Radiation Therapy for Boosting Residual Lung Cancer With Durvalumab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
ALICIA (Acalabrutinib in CLL Therapy)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Study of AZD2811 + Durvalumab in ES-SCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Trastuzumab Deruxtecan in Participants With HER2-overexpressing Advanced or Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Non-interventional, Prospective Study to Determine Prevalence of EGFR Mutations in Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- N/A
Capivasertib China PK Study
- Status
- COMPLETED
- Phase
- PHASE1